Showing results (91-100 of 215) with videos related to

Sort By:
Pageof 22
Vaccine|January 28, 2003
Generation of antigen-loaded dendritic cells in a serum-free medium using different cytokine combinationsTomas Büchler, Roman Hajek, Lida Bourkova, et al.
Haematologica|November 19, 2013
Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significanceLenka Kubiczkova, Fedor Kryukov, Ondrej Slaby, et al.
Leukemia Research|September 15, 2022
Evaluation of isatuximab in patients with soft-tissue plasmacytomas: An analysis from ICARIA-MM and IKEMAMeral Beksac, Ivan Spicka, Roman Hajek, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 25, 2022
Patient Characteristics, Treatment Patterns, and Outcomes in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma Patients, a Retrospective Observational Study Using Czech Registry DataVladimir Maisnar, Ludek Pour, Ivan Spicka, et al.
Oncotarget|October 13, 2016
CCR10/CCL27 crosstalk contributes to failure of proteasome-inhibitors in multiple myelomaShanmugapriya Thangavadivel, Claudia Zelle-Rieser, Angelika Olivier, et al.
Clinical Lymphoma & Myeloma|December 3, 2009
Long-term outcomes of autologous transplantation in multiple myeloma: significant survival benefit of novel drugs in post-transplantation relapseMarta Krejci, Vlastimil Scudla, Elen Tothova, et al.
Blood Cancer Journal|February 10, 2021
Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee ReportDavid L Murray, Noemi Puig, Sigurdur Kristinsson, et al.
Nature Communications|November 10, 2022
The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myelomaAlexander Vdovin, Tomas Jelinek, David Zihala, et al.
Biomed Research International|July 3, 2014
Genome-wide screening of cytogenetic abnormalities in multiple myeloma patients using array-CGH technique: a Czech multicenter experienceJan Smetana, Jan Frohlich, Romana Zaoralova, et al.
European Journal of Haematology|December 29, 2019
A phase 2 study of ibrutinib in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myelomaRoman Hajek, Ludek Pour, Muhit Ozcan, et al.
Pageof 22